Ipas Nigeria Health Foundation actively advocates for equitable health access for Persons with Disabilities (PWDs). Collaborating with DisabilityLed Organizations (DLOs) and Community-Based Organizations (CBOs) in states including Bauchi, Jigawa, Gombe, Ogun, Anambra, and Akwa Ibom, Ipas supports the development and domestication of national and state disability policies.

In Nigeria, where abortion is legally restricted, individuals seek medication abortion drugs, including misoprostol, directly from pharmacies or drug sellers. However, knowledgeof drug sellers or patent medicine vendors(PMVs) dispensation practices and women’sexperience with self-management is limited and research suggests poor quality of services. This study assesses the knowledge and practices ofPMVs and women’s experiences after a harm reduction intervention to improve the provision of medication abortion using misoprostol.

As the glaring inequity in maternal death ratios becomes more apparent between countries in theNorthern and Southern Hemispheres, health experts try to achieve a reduction in their own nations’ pregnancy-related deaths. Perhaps no research holds as much potential to make a difference in the developing world as research conducted on the gynaecological indications of misoprostol. The media tend to portray that misoprostol is widely available among private sector pharmaceutical distributors in Nigeria, yet evidence is lacking to that effect.

To examine the impact of a national intervention to improve the postabortion care (PAC) content of midwifery education in Nigeria.

Despite legal restriction, induced abortions and resulting complications are common in Nigeria. Misoprostol administration for incomplete abortion was introduced in 3 Nigerian hospitals. The feasibility of the hospitals, patient and provider acceptability were assessed using questionnaire and interview guides administered to 205 women and 17 providers respective

Abortion-related complications remain a main cause of maternal mortality. There is little evidence on the availability and quality of post-abortion care (PAC) in humanitarian settings. We assessed the quality of PAC in two hospitals supported by an international organization in Jigawa State (Nigeria) and Bangui (Central African Republic, CAR).

Fragile and crisis-affected countries account for most maternal deaths worldwide, with unsafe abortion being one of its leading causes. This case study aims to describe the Clinical Outreach Refresher Training strategy for sexual and reproductive health (S-CORT) designed to update health providers’ competencies on uterine evacuation using both medications and manual vacuum aspiration. The paper also explores stakeholders’ experiences, recommendations for improvement, and lessons learned.

Health worker performance has been the focus of numerous interventions and evaluation studies in low- and middle-income countries. Few have examined changes in individual provider performance with an intervention encompassing post-training support contacts to improve their clinical practice and resolve programmatic problems. This paper reports the results of an intervention with 3471 abortion providers in India, Nepal and Nigeria.

Unsafe abortion is a significant contributor to maternal mortality in Nigeria, and treatment of postabortion complications drains public healthcare resources. Provider estimates of medications, supplies, and staff time
spent in 17 public hospitals were used to estimate the per-case and annual costs of postabortion care (PAC) provision in Ogun and Lagos states and the Federal Capital Territory.